Photodynamic therapy induces interleukin secretion from dendritic cells

International Journal of Clinical and Experimental Medicine

Volumn 3, Issue 2, 2010, Pages 110-114

  Kushibiki, Toshihiro ^a   Tajiri, Takako ^a   Tomioka, Yutaka ^a   Awazu, Kunio ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Dendritic cells; Interleukin; Photodynamic therapy; Tumor immunity

Indexed keywords

CANCER VACCINE; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; IMMUNE RESPONSE; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PROTEIN EXPRESSION; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 77955586861     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Hsu FJ, Benike C, Fagnoni F, Liles TM, Czerwinski D, Taidi B, Engleman EG, and Levy R. Vaccination of patients with B-cell lymphoma using autologous antigen pulsed dendritic cells. Nat Med 1996; 2: 52-58.
2. Steinman RM and Pope M. Exploiting dendritic cells to improve vaccine efficacy. J Clin Invest 2002; 109: 1519-1526.
3. Banchereau J and Palucka K. Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 2005; 5: 296-306.
4. Fields RC, Shimizu K, and Mule JJ. Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo. Proc Natl Acad Sci USA 1998; 95: 9482-9487.
5. Song W, Kong HL, Carpenter H, Torii H, Granstein R, Rafii S, Moore MA, and Crystal RG. Dendritic cells geneticallymodifiedwith an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity. J Exp Med 1997; 186: 1247-1256.
6. Boczkowski D, Nair SK, Snyder D, and Gilboa E. Dendritic cells pulsed with RNA are potent antigenpresenting cells in vitro and in vivo. J Exp Med 1996; 184: 465-472.
7. Condon C, Watkins SC, Celluzzi CM, Thompson K, and Falo LD, Jr. DNA-based immunization by in vivo transfection of dendritic cells. Nat Med 1996; 2: 1122-1128.
8. Gong J, Chen D, Kashiwaba M, Kufe D. Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells. Nat Med 1997; 3: 558-561.
9. Figdor CG, DeVries JM, Lesterhuis WJ, and Melief CJM. Dendritic cell immunotherapy: mapping the way. Nat Med 2004; 10: 475-480.
10. Lightdale CJ, Heier SK, Marcon NE, McCaughan JS Jr, Gerdes H, Overholt BF, Sivak MV Jr, Stiegmann GV, and Nava HR. Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial. Gastrointest Endosc 1995; 42: 507-512.
11. Verma S, Watt GM, Mai Z, and Hasan T. Strategies for enhanced photodynamic therapy effects. Photochem Photobiol 2007; 83: 996-1005.
12. Buytaert E, Dewaele M, Agostinis P. Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochim Biophys Acta 2007; 1776: 86-107.
13. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, and Peng Q. Photodynamic therapy. J Natl Cancer Inst 1998; 90: 889-905.
14. [] Engleman EG, Brody J, and Soares L. Using signaling pathways to overcome immune tolerance to tumors. Sci STKE 2004; pe28.
15. Kushibiki T, Sakai M, and Awazu K. Differential effects of photodynamic therapy on morphologically distinct tumor cells derived from a single precursor cell. Cancer Lett 2008; 18: 244-251.
16. Kishimoto T. The biology of interleukin-6. Blood 1989; 74: 1-10.
17. Mule JJ, Custer MC, Travis WD, and Rosenberg SA. Cellular mechanisms of the antitumor activity of recombinant IL-6 in mice. J Immunol 1992; 148: 2622-2629.
18. Kick G, Messer G, Goetz A, Plewig G, and Kind P. Photodynamic therapy induces expression of interleukin 6 by activation of AP-l but not NF-kB DNA binding. Cancer Res 1995; 55: 2373-2379.
19. Evans S, Matthews W, Perry R, Fraker D, Norton J, and Pass HI. Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages. J Natl Cancer Inst 1990; 82: 34-39.
20. Anderson C, Hrabovsky S, McKinley Y, Tubesing K, Tang H, Dunbar R, Mukhtar H, and Elmets CA. Phthalocyanine photodynamic therapy: disparate effects of pharmacologic nhibitors on cutaneous photosensitivity and on tumor regression. Photochem Photobiol 1997; 65: 895-901.
21. Vincek V, Kurimoto I, Medema JP, Prieto E, and Streilein JW. Tumor necrosis factor a polymorphism correlates with deleterious effects of ultraviolet B light on cutaneous immunity. Cancer Res 1993; 53: 728-732.
22. Mullen CA, Coale MM, Levy AT, Stetler-Stevenson WG, Liofta LA, Brandt S, and Blaese RM. Fibrosarcoma cells transduced with the JL-6 gene exhibit reduced tumorigenicity, increased immunogenicity, and decreased metastatic potential. Cancer Res 1992; 52: 6020-6024.
23. Dougherty GJ, Thacker JD, Lavey RS, Belldegrun A, and McBride WH. Inhibitory effect oflocaily produced and exogenous interleukin-6 on tumor growth in vivo. Cancer Immunol Immunother 1994; 38: 339-345.
24. Lana MC, Wong S, and Gomer CJ. Photodynamic therapy mediated induction of early response genes. Cancer Res 1994; 54: 1374-1380.
25. Kick G, Messer G, Plewig G, Kind P, and Goetz AE. Strong and prolonged injunctionof c-jun and c-fos proto-oncogenesby photodynamictherapy. Br J Cancer 1996; 74: 30-36.
26. Gollnick SO, Vaughan L, and Henderson BW. Generation of effective antitumor vaccines using photodynamic therapy. Cancer Res 2002; 62: 1604-1608.
27. Sinkovics JG and Horvath JC. Vaccination against human cancers. Int J Oncol 2000; 16: 81-96.
28. Banchereau J, Schuler-Thurner B, Palucka AK, and Schuler G. Dendritic cells as vectors for therapy. Cell 2001; 106: 271-274.